# Artificial Intelligence and Digital Technology in Cardiovascular Imaging: A Narrative Review

**Authors:** Constantinos H. Papadopoulos, Dimitris Karelas, Christina Floropoulou, Konstantina Tzavida, Dimitrios Oikonomidis, Athanasios Tasoulis, Evangelos Tatsis, Ioannis Kouloulias, Nikolaos P. E. Kadoglou

PMC · DOI: 10.3390/biotech15010022 · BioTech · 2026-03-03

## TL;DR

AI and digital tools are transforming cardiovascular imaging by improving accuracy, speed, and accessibility, though challenges remain in validation and regulation.

## Contribution

This review highlights recent AI applications in cardiovascular imaging and identifies challenges for clinical integration.

## Key findings

- AI improves image quality, reduces analysis time, and enables automated measurements in cardiovascular imaging.
- Digital platforms support remote imaging and training of non-expert operators.
- Challenges include validation, generalizability, and ethical-legal frameworks for AI adoption.

## Abstract

The rapid expansion of digital technologies and artificial intelligence (AI) has profoundly transformed cardiovascular imaging, enabling more precise, efficient, and reproducible assessment of cardiac structure and function. This narrative review summarizes recent advances in AI-driven methods across echocardiography, cardiac computed tomography, cardiac magnetic resonance, and nuclear imaging, with emphasis on image acquisition, automated quantification, and diagnostic and prognostic interpretation. We reviewed contemporary literature describing machine-learning and deep-learning applications for image reconstruction, segmentation, radiomics, and multimodal data integration. Current evidence demonstrates that AI improves image quality, reduces acquisition and analysis time, and enables automated, highly reproducible measurements of chamber volumes, function, tissue characterization, coronary anatomy, and myocardial perfusion, while facilitating advanced pattern recognition for differential diagnosis and risk stratification. Furthermore, digital platforms support remote acquisition, tele-echocardiography, and AI-assisted training of non-expert operators. Despite these advances, challenges remain regarding external validation, generalizability across vendors and populations, explainability, data governance, and regulatory compliance. In conclusion, AI and digital technologies are reshaping cardiovascular imaging by enhancing accuracy, efficiency, and accessibility, but their safe and effective clinical integration requires robust multicenter validation, transparent reporting, and ethical-legal frameworks that ensure trust, equity, and accountability.

## Full-text entities

- **Diseases:** cancer (MESH:D009369), infarction (MESH:D007238), fibrosis (MESH:D005355), death (MESH:D003643), systole (MESH:D000092244), myocardial disease (MESH:D004194), left ventricular hypertrophy (MESH:D017379), injury to (MESH:D014947), pericarditis (MESH:D010493), myocardial infarction (MESH:D009203), AI (MESH:C538142), ischemic (MESH:D002545), stroke (MESH:D020521), inflammatory (MESH:D007249), coronary artery disease (MESH:D003324), congenital defects (MESH:D000013), ischemic cardiomyopathy (MESH:D009202), diastole (MESH:D006337), dilated cardiomyopathy (MESH:D002311), myocarditis (MESH:D009205), stenoses (MESH:D003251), cardiotoxicity (MESH:D066126)
- **Chemicals:** gadolinium (MESH:D005682)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13024323/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024323/full.md

## References

53 references — full list in the complete paper: https://tomesphere.com/paper/PMC13024323/full.md

---
Source: https://tomesphere.com/paper/PMC13024323